Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Anebulo Pharmaceuticals Q2 EPS $(0.15) Misses $(0.11) Estimate

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 200 percent decrease over losses of $(0.05) per

byBenzinga Newsdesk

February 10, 2023

1 minute read

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 200 percent decrease over losses of $(0.05) per share from the same period last year.